Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 01/07/22
Simulations Plus Sets Date for First Quarter Fiscal Year 2022 Earnings Release and Conference CallBusiness Wire • 12/20/21
Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™Business Wire • 12/02/21
Simulations Plus celebrates 25-year anniversary with $25,000 gift to nonprofit Dispensary of HopePRNewsWire • 11/30/21
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit, Dispensary of HopeBusiness Wire • 11/30/21
Simulations Plus Presented Breakthrough Scientific Data at Top Liver Disease ConferenceBusiness Wire • 11/18/21
Simulations Plus and the University of Connecticut Awarded New FDA Contract to Accelerate the Development of Long-Acting Injectable ProductsBusiness Wire • 10/26/21
Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/26/21
Earnings Preview: Simulations Plus (SLP) Q4 Earnings Expected to DeclineZacks Investment Research • 10/18/21